Full-Life Technologies
高管
查看带有其 17 名主要高管的组织结构图
Full-Life Technologies 搜索最多的简介
- Lanny Sun, Co-Founder, Chairman and Chief Executive Officer
- Edward Myles, Director
- Philippe Van Put, General Manager, Europe
高管在Full-Life Technologies变化
- Edward Myles已作为Director加入公司 (新闻发布的2024七月22号).
- Mark De Jong已作为Chief Technical Officer加入公司 (新闻发布的2024五月19号).
创建提醒
跟踪 Full-Life Technologies 的高管变动
医疗设备
Full-Life Technologies 拥有 1,005 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- Precision Neuroscience 刚刚宣布为 102 筹款数百万美元。 (公布2024十二月18号).
- electroCore 已收购 NeuroMetrix (公布2024十二月18号).
- Anteris Technologies 刚刚宣布为 89 筹款数百万美元。 (公布2024十二月16号).
医疗设备 行业的其他推荐联系人
消息
Full-Life Technologies 的最新新闻稿
- Full-Life Technologies Announced the Progress of its Radioisotope Manufacturing Facility in Belgium-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announced the Progress of its Radioisotope Manufacturing Facility in Belgium-Press Releas
- Full-Life Technologies to Present Three Top Rated Oral Presentations at the 37th Annual Congress of the European Association of Nuclear Medicine-Press Releases-From Half-Life to Full-Life.Full-Life Technologies to Present Three Top Rated Oral Presentation
- Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors-Press Releases-Fro
- Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors-Press Releases-From Half-Life to Full-Life.Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Ther
- Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-
- Press Releases-From Half-Life to Full-Life.Press Releases-From Half-Life to Full-Life.
- Full-Life Technologies Announces Clearance from FDA of IND Application for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces Clearance from FDA of
- Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Disclosed Preclinical Data of its NTSR1-
- Full-Life Technologies will showcase preclinical data of its NTSR1-targeted RDC program FL-091 in an oral presentation at the 2024 SNMMI Annual Meeting-Press Releases-From Half-Life to Full-Life.Full-Life Technologies will showcase preclinical data of its
- Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer-Press Releases-From Half-Life to Full-Life.Full-Life Technologies Announces Appointment of Mark S. de Jong, PhD, as Chief Technical Officer-Press Releases-F
- View more press releases Close
